Test of Cure for Bacterial Vaginosis
For bacterial vaginosis (BV), a test of cure is not routinely recommended for non-pregnant women if symptoms resolve after treatment, but is recommended one month after treatment completion for pregnant women due to potential pregnancy complications.
General Recommendations for Test of Cure
Non-Pregnant Women
- Test of cure is not routinely recommended if symptoms resolve after treatment 1, 2
- Follow-up visits are unnecessary if symptoms resolve completely 1
- Patients should return for additional treatment if symptoms recur 1
Pregnant Women
- A follow-up evaluation one month after completion of treatment is recommended for all pregnant women 1
- This is particularly important because BV is associated with:
Rationale for Different Approaches
Why Test of Cure is Not Needed for Most Non-Pregnant Women
- Standard treatment regimens (metronidazole or clindamycin) have high efficacy rates of 75-95% 2
- Clinical improvement should be evident within days of starting treatment
- The absence of symptoms generally indicates successful treatment
Why Test of Cure is Important in Pregnancy
- The stakes are higher due to potential adverse pregnancy outcomes 1
- Verification of treatment effectiveness helps reduce risks to both mother and fetus
- Even asymptomatic BV can lead to pregnancy complications 3
Managing Recurrent BV
- Recurrence rates for BV are high (50-80% within one year after treatment) 4, 5
- If symptoms recur after initial treatment:
Special Considerations
HIV-Infected Patients
- Patients with BV and HIV should receive the same treatment regimen as those without HIV 1
- The same test of cure guidelines apply based on pregnancy status
After Gynecological Procedures
- BV increases risk of post-procedure infections including:
- Post-abortion PID
- Endometritis
- Vaginal cuff cellulitis after hysterectomy 2
- Consider screening and treating BV before surgical procedures 2
Common Pitfalls to Avoid
- Premature testing: Testing too soon after treatment completion (less than 3-4 weeks) may yield false results
- Confusing test of cure with routine rescreening: Test of cure is specifically to verify treatment success, while rescreening is for detecting new infections
- Ignoring partner treatment: While routine treatment of male partners is not recommended for BV 1, persistent recurrence may warrant consideration of partner treatment in some cases
- Overlooking non-adherence: Treatment failure may be due to incomplete treatment course rather than true resistance
By following these guidelines, clinicians can appropriately determine when a test of cure is necessary for bacterial vaginosis, optimizing patient care while avoiding unnecessary testing.